financetom
Business
financetom
/
Business
/
TSMC Reports 33% Increase in August Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TSMC Reports 33% Increase in August Revenue
Sep 10, 2024 6:02 PM

06:09 AM EDT, 09/10/2024 (MT Newswires) -- Taiwan Semiconductor Manufacturing ( TSM ) reported Tuesday revenue of $250.87 billion New Taiwan dollars ($7.97 billion) in August, up 33% from a year earlier.

For the January to August period, revenue increased 31% to NT$1.773 trillion.

Price: 160.04, Change: -2.74, Percent Change: -1.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JetBlue Raises Q3 Outlook on Strong Summer Demand, Cuts Capital Spending Guidance
JetBlue Raises Q3 Outlook on Strong Summer Demand, Cuts Capital Spending Guidance
Sep 4, 2025
08:09 AM EDT, 09/04/2025 (MT Newswires) -- JetBlue Airways ( JBLU ) said Thursday for its third quarter ending Sept. 30, it expects Operating Revenue per Available Seat Mile to contract between 4% to 1.5%, down from its earlier outlook of 6% to 2% reduction. The company said that demand for air travel remained strong throughout the summer peak and...
Ivanhoe Electric-Saudi Arabian Mining JV Secures New Exploration Licenses
Ivanhoe Electric-Saudi Arabian Mining JV Secures New Exploration Licenses
Sep 4, 2025
08:11 AM EDT, 09/04/2025 (MT Newswires) -- Ivanhoe Electric ( IE ) said Thursday that its joint venture with Saudi Arabian Mining has received an additional 1,345 square kilometers of exploration licenses in Saudi Arabia. The Musayna'ah licenses cover 946 square kilometers and show evidence of Iron Oxide-Copper-Gold type alteration and mineralization, the company said. The Mahd Area licenses, located...
Agios Pharmaceuticals Says FDA Extends PDUFA Goal Date for Thalassemia Treatment NDA to Dec. 7
Agios Pharmaceuticals Says FDA Extends PDUFA Goal Date for Thalassemia Treatment NDA to Dec. 7
Sep 4, 2025
08:06 AM EDT, 09/04/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) said Thursday the US Food and Drug Administration has extended the target date to approve the company's supplemental new drug application of Pyrukynd for treating adults with thalassemia by three months to Dec. 7. The agency requested a proposed risk evaluation and mitigation strategy to address potential liver...
C4 Therapeutics Says Biogen's IND Application Accepted by FDA to Treat Autoimmune Diseases
C4 Therapeutics Says Biogen's IND Application Accepted by FDA to Treat Autoimmune Diseases
Sep 4, 2025
08:11 AM EDT, 09/04/2025 (MT Newswires) -- C4 Therapeutics ( CCCC ) said Thursday that its partner Biogen's (BIIB) investigational new drug application for BIIB142, a degrader of IRAK4, was accepted by the US Food and Drug Administration. Biogen plans to explore the therapeutic use of BIIB142 in patients with autoimmune diseases, the biopharmaceutical company said. Under the terms of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved